The p53-dependent expression of frataxin controls 5-aminolevulinic acid-induced accumulation of protoporphyrin IX and photo-damage in cancerous cells

Photochemistry and Photobiology

Volumn 89, Issue 1, 2013, Pages 163-172

  Sawamoto, Mari ^a   Imai, Takafumi ^a   Umeda, Mana ^a   Fukuda, Koji ^a   Kataoka, Takao ^a   Taketani, Shigeru ^a  

^a KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; FERROCHELATASE; FRATAXIN; IRON; IRON BINDING PROTEIN; PROTEIN P53; PROTOPORPHYRIN; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; MOUSE; PROMOTER REGION; PROTEIN BINDING; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMINOLEVULINIC ACID; ANIMALS; CELL LINE, TUMOR; FERROCHELATASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IRON; IRON-BINDING PROTEINS; MICE; MITOCHONDRIA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTOPORPHYRINS; RESPONSE ELEMENTS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

BACTERIA (MICROORGANISMS);

EID: 84872044313     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2012.01215.x     Document Type: Article

References (39)

1. Ye, H., and, T. A. Rouault, (2010) Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 49, 4945-4956.
2. Stemmler, T. L., E. Lesuisse, D. Pain, and, A. Dancis, (2010) Frataxin and mitochondrial FeS cluster biogenesis. J. Biol. Chem. 285, 26737-26743.
3. Thierbach, R., T. J. Schulz, F. Isken, A. Voigt, B. Mietzner, G. Drewes, J. C. von Kleist-Retzow, R. J. Wiesner, M. A. Magnuson, H. Puccio, A. F. Pfeiffer, P. Steinberg, and, M. Ristow, (2005) Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum. Mol. Genet. 14, 3857-3864. (Pubitemid 43020087)
4. Shoichet, S. A., A. T. Bäumer, D. Stamenkovic, H. Sauer, A. F. Pfeiffer, C. R. Kahn, D. Müller-Wieland, C. Richter, and, M. Ristow, (2002) Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro. Hum. Mol. Genet. 11, 815-821. (Pubitemid 34428649)
5. Schulz, T. J., R. Thierbach, A. Voigt, G. Drewes, B. Mietzner, P. Steinberg, A. F. Pfeiffer, and, M. Ristow, (2006) Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited. J. Biol. Chem. 281, 977-981.
6. Ohgari, Y., Y. Miyata, T. Miyagi, S. Gotoh, T. Ohta, T. Kataoka, K. Furuyama, and, S. Taketani, (2011) Roles of porphyrin and iron metabolisms in the δ-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin and photo-damage of tumor cells. Photochem. Photobiol. 87, 1138-1145.
7. Guccini, I., D. Serio, I. Condò, A. Rufini, B. Tomassini, A. Mangiola, G. Maira, C. Anile, D. Fina, F. Pallone, M. P. Mongiardi, A. Levi, N. Ventura, R. Testi, and, F. Malisan, (2011) Frataxin participates to the hypoxia-induced response in tumors. Cell Death Dis. 2, e123.
8. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and, Q. Peng, (1998) Photodynamic therapy. J. Natl Cancer Inst. 9, 889-905. (Pubitemid 28304157)
9. Evangelou, G., M. D. Farrar, R. D. White, N. B. Sorefan, K. P. Wright, K. McLean, S. Andrew, R. E. Watson, and, L. E. Rhodes, (2011) Topical aminolaevulinic acid-photodynamic therapy produces an inflammatory infiltrate but reduces Langerhans cells in healthy human skin in vivo. Br. J. Dermatol. 165, 513-519.
10. Sakamoto, F. H., A. G. Doukas, W. A. Farinelli, Z. Tannous, Y. Su, N. A. Smith, D. Zurakowski, and, R. R. Anderson, (2011) Intracutaneous ALA photodynamic therapy: Dose-dependent targeting of skin structures. Lasers Surg. Med. 43, 621-631.
11. Muschter, R., (2003) Photodynamic therapy: A new approach to prostate cancer. Curr. Urol. Rep. 4, 221-228.
12. Ohgari, Y., Y. Nakayasu, S. Kitajima, M. Sawamoto, H. Mori, O. Shimokawa, H. Matsui, and, S. Taketani, (2005) Mechanisms involved in δ- aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: Relation of ferrochelatase and uptake of ALA by cells to the accumulation of protoporphyrin. Biochem. Pharmacol., 71, 42-49. (Pubitemid 41713525)
13. Yamamoto, F., Y. Ohgari, N. Yamaki, S. Kitajima, O. Shimokawa, H. Matsui, and, S. Taketani, (2007) The role of nitric oxide in δ-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells. Biochem. Biophys. Res. Commun. 353, 541-546. (Pubitemid 46048703)
14. Feuerstein, T., A. Schauder, and, Z. Malik, (2009) Silencing of ALA dehydratase affects ALA-photodynamic therapy efficacy in K562 erythroleukemic cells. Photochem. Photobiol. Sci. 8, 1461-1466.
15. Schauder, A., T. Feuerstein, and, Z. Malik, (2011) The centrality of PBGD expression levels on ALA-PDT efficacy. Photochem. Photobiol. Sci. 10, 1310-1317.
16. Krishnamurthy, P., T. Xie, and, J. D. Schuetz, (2007) The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol. Ther. 114, 345-358. (Pubitemid 46843250)
17. Liu, D., and, Y. Xu, (2011) p53, oxidative stress, and aging. Antioxid. Redox Signal. 215, 1669-1678.
18. Asher, G., J. Lotem, B. Cohen, L. Sachs, and, Y. Shaul, (2001) Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl. Acad. Sci. U.S.A. 98, 1188-1193. (Pubitemid 32121208)
19. Ohgari, Y., M. Sawamoto, H. Kohno, and, S. Taketani, (2005) Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer. Hum. Mol. Genet. 14, 327-334.
20. Gotoh, S., Y. Ohgari, T. Nakamura, T. Osumi, and, S. Taketani, (2008) Heme-binding to the nuclear receptor retinoid X receptor alpha (RXRalpha) leads to the inhibition of the transcriptional activity. Gene 423, 207-214.
21. Tahara, T., J. Sun, K. Nakanishi, M. Yamamoto, H. Mori, H. Fujita, K. Igarashi, and, S. Taketani, (2004) Heme positively regulates the expression of β-globin at the locus control region via the transcriptional factor Bach1 in erythroid cells. J. Biol. Chem. 279, 5480-5487. (Pubitemid 38220572)
22. Mizutani, A., T. Furukawa, Y. Adachi, S. Ikehara, and, S. Taketani, (2002) A zinc-finger protein, PLAGL2, induces the expression of a proapoptotic protein Nip3, leading to cellular apoptosis. J. Biol. Chem. 277, 15851-15858. (Pubitemid 34967864)
23. Gotoh, S., T. Nakamura, T. Kataoka, and, S. Taketani, (2011) Egr-1 regulates the transcriptional repression of mouse δ-aminolevulinic acid synthase 1 by heme. Gene 472, 28-36.
24. Park, D. J., H. Nakamura, A. M. Chumakov, J. W. Said, C. W. Miller, D. L. Chen, and, H. P. Koeffler, (1994) Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene 9, 1899-1906. (Pubitemid 24194156)
25. Müller, M., S. Strand, H. Hug, E. M. Heinemann, H. Walczak, W. J. Hofmann, W. Stremmel, P. H. Krammer, and, P. R. Galle, (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99, 403-413. (Pubitemid 27414797)
26. An, W. G., M. Kanekal, M. C. Simon, E. Maltepe, M. V. Blagosklonny, and, L. M. Neckers, (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature, 392, 405-408.
27. Will, K., G. Warnecke, N. Albrechtsen, T. Boulikas, and, W. Deppert, (1998) High affinity MAR-DNA binding is a common property of murine and human mutant p53. J. Cell. Biochem. 69, 260-270. (Pubitemid 28227703)
28. Yoon, T., and, J. A. Cowan, (2004) Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J. Biol. Chem. 279, 25943-25946. (Pubitemid 38798734)
29. Ventura, N., S. L. Rea, A. Schiavi, A. Torgovnick, R. Testi, and, T. E. Johnson, (2009) p53/CEP-1 increases or decreases lifespan, depending on level of mitochondrial bioenergetic stress. Aging Cell 8, 380-393.
30. Torgovnick, A., A. Schiavi, R. Testi, and, N. Ventura, (2010) A role for p53 in mitochondrial stress response control of longevity in C. elegans. Exp. Gerontol. 45, 550-557.
31. Palomo, G. M., T. Cerrato, R. Gargini, and, J. Diaz-Nido, (2011) Silencing of frataxin gene expression triggers p53-dependent apoptosis in human neuron-like cells. Hum. Mol. Genet. 20, 2807-2822.
32. Ristow, M., M. F. Pfister, A. J. Yee, M. Schubert, L. Michael, C. Y. Zhang, K. Ueki, M. D. Michael 2nd, B. B. Lowell, and, C. R. Kahn, (2000) Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 97, 12239-12243.
33. Bulteau, A. L., H. A. O'Neill, M. C. Kennedy, M. Ikeda-Saito, G. Isaya, and, L. I. Szweda, (2004) Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 305, 242-245. (Pubitemid 38886737)
34. Taketani, S., Y. Adachi, and, Y. Nakahashi, (2000) Regulation of the expression of human ferrochelatase by intracellular iron levels. Eur. J. Biochem. 267, 4685-4692. (Pubitemid 30619458)
35. Schoenfeld, R. A., E. Napoli, A. Wong, S. Zhan, L. Reutenauer, D. Morin, A. R. Buckpitt, F. Taroni, B. Lonnerdal, M. Ristow, H. Puccio, and, G. A. Cortopassi, (2005) Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells. Hum. Mol. Genet. 15, 3787-3799. (Pubitemid 43020081)
36. Teng, L., M. Nakada, S. G. Zhao, Y. Endo, N. Furuyama, E. Nambu, I. V. Pyko, Y. Hayashi, and, J. I. Hamada, (2011) Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br. J. Cancer 104, 798-807.
37. Hinnen, P., F. W. de Rooij, E. M. Terlouw, A. Edixhoven, H. van Dekken, R. van Hillegersberg, H. W. Tilanus, J. H. Wilson, and, P. D. Siersema, (2000) Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid. Br. J. Cancer 83, 539-543. (Pubitemid 30487870)
38. Sinha, A. K., S. Anand, B. J. Ortel, Y. Chang, Z. Mai, T. Hasan, and, E. V. Maytin, (2006) Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br. J. Cancer 95, 485-495. (Pubitemid 44232558)
39. Meiller, A., S. Alvarez, P. Drané, C. Lallemand, B. Blanchard, M. Tovey, and, E. May, (2007) p53-dependent stimulation of redox-related genes in the lymphoid organs of gamma-irradiated-mice identification of Haeme-oxygenase 1 as a direct p53 target gene. Nucleic Acids Res. 35, 6924-6934. (Pubitemid 350201811)